Clinical Trial Update: MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic comparison of MQX-503 applied to the hand versus nitroglycerin ointment applied to the chest for Raynaud's Phenomenon; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon

Drugs mentioned

• MQX-503
• Nitroglycerin ointment (nitroglycerin)

Snippet

Sponsor: MediQuest Therapeutics | Conditions: Raynaud's Phenomenon | Phase 1 | Status: COMPLETED